Exhibit A
AGREEMENT
The undersigned agree that this Amendment No. 3 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.001 per share, of Adamas Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.
| Armistice Capital, LLC | ||
| By: | /s/ Steven Boyd | |
| Steven Boyd | ||
| Managing Member | ||
/s/ Steven Boyd | ||
| Steven Boyd | ||
